Literature DB >> 25655346

The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.

Manon M H Huibers1, Alison J Gareau2, Aryan Vink3, Rianne Kruit3, Hannah Feringa3, Johanna M T Beerthuijzen3, Erica Siera-de Koning3, Ton Peeters3, Nicolaas de Jonge4, Roel A de Weger3, Timothy D G Lee5.   

Abstract

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a multifactorial pathology limiting the survival of cardiac transplants. The etiology of CAV is unclear, but antibody-mediated and cellular-mediated responses have been implicated. We, and others, have observed ectopic lymphoid structures (ELS) surrounding epicardial coronary arteries with CAV. The potential contribution of these ELS to CAV has not been elucidated.
METHODS: Epicardial coronary arteries were collected from 59 transplant patients at 2 centers and studied for ELS presence and composition using immunohistochemistry. The intima and ELS were isolated, and the expression of the genes involved in tertiary lymphoid organ (TLO) formation was measured by quantitative polymerase chain reaction.
RESULTS: ELS presence was related to survival after transplantation (p = 0.013) and histologic composition of CAV (p < 0.001). ELS contain B and T lymphocytes, macrophages, and antibody-producing (immunoglobulin [Ig] M and/or IgG) plasma cells. A sub-population of B lymphocytes appeared to be cluster of differentiation (CD)20(+)CD27(+) memory B lymphocytes. The messenger RNA expression of TLO markers (lymphotoxin-β, and chemokine [C-C motif] ligand 19 and 21) was significantly higher in ELS than in the neointimal lesions. The ELS observed in this study exhibited some TLO markers but did not exhibit the distinct areas rich in B and T lymphocytes that are normally found in classic TLOs.
CONCLUSIONS: The cellular composition of the ELS differs from the cellular infiltrate in CAV intimal lesions. The presence of memory B lymphocytes and plasma producing IgM and IgG cells suggests that ELS are related to local antibody production, potentially contributing to antibody-mediated CAV. ELS associated with coronary vessels containing CAV show features of underdeveloped TLOs; classic TLOs may not develop due to patient immunosuppression.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B lymphocytes; allograft vasculopathy; cardiac transplantation; lymphoid neogenesis

Mesh:

Year:  2014        PMID: 25655346     DOI: 10.1016/j.healun.2014.11.022

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  16 in total

1.  Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection.

Authors:  Wenjun Li; Jason M Gauthier; Ryuji Higashikubo; Hsi-Min Hsiao; Satona Tanaka; Linh Vuong; Jon H Ritter; Alice Y Tong; Brian W Wong; Ramsey R Hachem; Varun Puri; Ankit Bharat; Alexander S Krupnick; Chyi S Hsieh; William M Baldwin; Francine L Kelly; Scott M Palmer; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

Review 2.  New insights on innate B-cell immunity in transplantation.

Authors:  Emmanuel Zorn
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

3.  B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.

Authors:  Carolina Moore; Baoshan Gao; Krishna M Roskin; Elena-Rodica M Vasilescu; Linda Addonizio; Michael M Givertz; Joren C Madsen; Emmanuel Zorn
Journal:  Am J Transplant       Date:  2019-12-27       Impact factor: 8.086

Review 4.  Is There a Role for Natural Antibodies in Rejection Following Transplantation?

Authors:  Emmanuel Zorn; Sarah B See
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

Review 5.  The Role of Lymphoid Neogenesis in Allografts.

Authors:  H-M Hsiao; W Li; A E Gelman; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

Review 6.  The importance of non-HLA antibodies in transplantation.

Authors:  Qiuheng Zhang; Elaine F Reed
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

7.  Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.

Authors:  Debanjana Chatterjee; Carolina Moore; Baoshan Gao; Kevin J Clerkin; Sarah B See; David Shaked; Kortney Rogers; Sarah Nunez; Yokarla Veras; Linda Addonizio; Michael M Givertz; Yoshifumi Naka; Donna Mancini; Rodica Vasilescu; Charles Marboe; Susan Restaino; Joren C Madsen; Emmanuel Zorn
Journal:  J Heart Lung Transplant       Date:  2017-09-28       Impact factor: 10.247

8.  Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies.

Authors:  Benjamin S Mantell; Hector Cordero; Sarah B See; Kevin J Clerkin; Rodica Vasilescu; Charles C Marboe; Yoshifumi Naka; Susan Restaino; Paolo C Colombo; Linda J Addonizio; Maryjane A Farr; Emmanuel Zorn
Journal:  J Heart Lung Transplant       Date:  2021-07-08       Impact factor: 10.247

Review 9.  Effector B cells in cardiac allograft vasculopathy.

Authors:  Emmanuel Zorn
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

10.  T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy.

Authors:  Marlena V Habal; April M I Miller; Samhita Rao; Sijie Lin; Aleksandar Obradovic; Mohsen Khosravi-Maharlooei; Sarah B See; Poulomi Roy; Ronzon Shihab; Siu-Hong Ho; Charles C Marboe; Yoshifumi Naka; Koji Takeda; Susan Restaino; Arnold Han; Donna Mancini; Michael Givertz; Joren C Madsen; Megan Sykes; Linda J Addonizio; Maryjane A Farr; Emmanuel Zorn
Journal:  Am J Transplant       Date:  2020-10-26       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.